Endometriosis and Peptides: What the Research Says About BPC-157, KPV, and Immune Support

Endometriosis affects an estimated 1 in 10 women of reproductive age, causing chronic pelvic pain, heavy periods, fatigue, and in many cases, infertility. Standard treatments — hormonal suppression, pain management, and surgical excision — address symptoms but don’t resolve the underlying inflammatory and immune dysfunction that drives the disease. Peptide research is opening new conversations about anti-inflammatory and tissue-modulating approaches that may complement existing care.

Why Peptides for Endometriosis?

Endometriosis is fundamentally an inflammatory and immune-mediated condition. Endometrial tissue growing outside the uterus triggers a chronic inflammatory response, activates the immune system, and creates an environment of oxidative stress and tissue damage. Peptides that modulate inflammation, support tissue repair, and influence immune function have theoretical relevance.

BPC-157 — Anti-Inflammatory and Tissue Repair

BPC-157’s anti-inflammatory properties are well-documented in animal models of gut inflammation, which shares pathological mechanisms with endometriosis (chronic inflammation, tissue damage, aberrant angiogenesis). Its ability to modulate the nitric oxide system and reduce pro-inflammatory cytokines makes it theoretically relevant for the inflammatory component of endometriosis.

For women with endometriosis who also experience GI symptoms (common — endometriosis frequently affects the bowel), BPC-157’s gut-protective effects add another layer of relevance.

KPV — Anti-Inflammatory Tripeptide

KPV is a fragment of alpha-melanocyte stimulating hormone (alpha-MSH) with documented anti-inflammatory effects. It reduces pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1beta) through the melanocortin pathway. Endometriosis is characterized by elevated levels of exactly these cytokines in peritoneal fluid. While direct endometriosis research is lacking, the mechanistic overlap is clear.

Thymosin Alpha-1 — Immune Modulation

Thymosin Alpha-1 modulates immune function at the T-cell level. Endometriosis involves immune surveillance dysfunction — the immune system fails to clear ectopic endometrial tissue. Thymosin Alpha-1’s ability to enhance immune recognition could theoretically support the body’s natural ability to identify and manage ectopic tissue.

NAD+ — Oxidative Stress and Energy

Endometriosis creates significant oxidative stress, and NAD+ depletion is associated with mitochondrial dysfunction in chronic inflammatory conditions. NAD+ supplementation may support cellular energy production and antioxidant defense in the context of chronic inflammation.

Where to Source These Peptides

Frequently Asked Questions

Related Articles